View : 71 Download: 0

Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice

Title
Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice
Authors
Park J.-S.Shin J.A.Jung J.-S.Hyun J.-W.Van Le T.K.Kim D.-H.Park E.-M.Kim H.-S.
Ewha Authors
김희선박은미
SCOPUS Author ID
김희선scopus; 박은미scopus
Issue Date
2012
Journal Title
Journal of Pharmacology and Experimental Therapeutics
ISSN
0022-3565JCR Link
Citation
vol. 341, no. 1, pp. 59 - 67
Indexed
SCI; SCIE; SCOPUS WOS scopus
Abstract
Microglial activation plays a pivotal role in the pathogenesis of various neurologic disorders, such as cerebral ischemia, Alzheimer's disease, and Parkinson's disease. Thus, controlling microglial activation is a promising therapeutic strategy for such brain diseases. In the present study, we found that a ginseng saponin metabolite, compound K [20-O-D-glucopyranosyl- 20(S)-protopanaxadiol], inhibited the expressions of inducible nitric-oxide synthase, proinflammatory cytokines, monocyte chemotactic protein-1, matrix metalloproteinase-3, and matrix metalloproteinase-9 in lipopolysaccharide (LPS)- stimulated BV2 microglial cells and primary cultured microglia. Subsequent mechanistic studies revealed that compound K suppressed microglial activation via inhibiting reactive oxygen species, mitogen-activated protein kinases, and nuclear factor-κB/ activator protein-1 activities with enhancement of heme oxygenase-1/antioxidant response element signaling. To address the anti-inflammatory effects of compound K in vivo, we used two brain disease models of mice: sepsis (systemic inflammation) and cerebral ischemia. Compound K reduced the number of Iba1-positive activated microglia and inhibited the expressions of tumor necrosis factor-α and interleukin-1β in the LPS-induced sepsis brain. Furthermore, compound K reduced the infarct volume of ischemic brain induced by middle cerebral artery occlusion and suppressed microglial activation in the ischemic cortex. The results collectively suggest that compound K is a promising agent for prevention and/or treatment of cerebral ischemia and other neuroinflammatory disorders. Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics.
DOI
10.1124/jpet.111.189035
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE